AMP-Activated Protein Kinase Alpha-2-Beta-2-Gamma-2: A Potential Drug Target and Biomarker

Target Name: AMP-activated protein kinase alpha2beta2gamma2

NCBI ID: P38823

AMP-activated protein kinase alpha2beta2gamma2

Other Name(s): AMPK alpha2beta2gamma2

AMP-Activated Protein Kinase Alpha-2-Beta-2-Gamma-2: A Potential Drug Target and Biomarker

AMP-activated protein kinase (AMPK) is a protein that plays a crucial role in cellular signaling.AMPK is a highly conserved, serine-threonine kinase that is involved in the regulation of a wide range of cellular processes, including metabolism, growth, and stress responses.AMPK has been implicated in many diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

The 伪2-尾2-纬2 fragment of AMPK, also known asAMP-activated protein kinase alpha2beta2gamma2 (AMPK alpha2beta2gamma2), is a key regulatory subunit that has been extensively studied.AMP-activated protein kinase alpha2beta2gamma2 is a 21-kDa protein that is involved in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

AMP-activated protein kinase alpha2beta2gamma2 (AMPK alpha2beta2gamma2) as a drug target

AMP-activated protein kinase alpha2beta2gamma2 (AMPK alpha2beta2gamma2) is a potential drug target in cancer, neurodegenerative diseases, and cardiovascular diseases. Studies have shown that AMPK alpha2beta2gamma2 is involved in the regulation of cellular processes that are crucial for disease progression.

For example, AMPK alpha2beta2gamma2 has been shown to be involved in cancer cell growth and survival. AMPK alpha2beta2gamma2 has been shown to inhibit the growth of cancer cells by suppressing the S6/P21 pathway, which is a key pathway involved in cell growth and survival.

In addition, AMPK alpha2beta2gamma2 has been shown to be involved in neurodegenerative diseases. AMPK alpha2beta2gamma2 has been shown to contribute to the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

AMP-activated protein kinase alpha2beta2gamma2 (AMPK alpha2beta2gamma2) as a biomarker

AMP-activated protein kinase alpha2beta2gamma2 (AMPK alpha2beta2gamma2) may also be used as a biomarker for some diseases. For example, AMPK alpha2beta2gamma2 has been shown to be involved in the regulation of body weight and obesity. AMPK alpha2beta2gamma2 has been shown to contribute to the regulation of energy metabolism and body weight, which may be related to the development of obesity.

In addition, AMP-activated protein kinase alpha2beta2gamma2 (AMPK alpha2beta2gamma2) has been shown to be involved in the regulation of inflammation. AMPK alpha2beta2gamma2 has been shown to contribute to the regulation of inflammatory responses, which may be related to the development of inflammatory diseases.

Conclusion

AMP-activated protein kinase alpha2beta2gamma2 (AMPK alpha2beta2gamma2) is a protein that has been extensively studied for its role in cellular signaling. Studies have shown that AMPK alpha2beta2gamma2 is involved in the regulation of a wide range of cellular processes, including cell growth, apoptosis, and inflammation.

AMP-activated protein kinase alpha2beta2gamma2 (AMPK alpha2beta2gamma2) may be a potential drug target and biomarker for cancer, neurodegenerative diseases, and cardiovascular diseases. Further studies are needed to fully understand the role of AMP-activated protein kinase alpha2beta2gamma2 (AMPK alpha2beta2gamma2) in disease progression.

Protein Name: AMP-activated Protein Kinase Alpha2beta2gamma2

The "AMP-activated protein kinase alpha2beta2gamma2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AMP-activated protein kinase alpha2beta2gamma2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets